NAT2 and presbycusis: The frequency of the NAT2*6A mutant genotype (heterozygous and null genotype combined) was more frequent among patients with presbycusis (60%) than in controls (34%; P = 0.0086, OR = 2.88, 95% confidence interval [95% CI] = 1.355–6.141).